Latest Mrna Podcast Episodes
Diffuse intrinsic pontine glioma
The Lancet Oncology in conversation with - August 14, 2018 19:00 - 22 minutes ★★★★★ - 1 ratingMark Souweidane joins The Lancet Oncology to discuss his dose-escalation study, assessing a convection-enhanced delivery for diffuse intrinsic pontine glioma. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet &...
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer
The Lancet Oncology in conversation with - June 30, 2018 06:30 - 9 minutes ★★★★★ - 1 ratingBo Jan Noordman joins The Lancet Oncology to discuss the findings from his study of residual disease detection in oesophageal cancer. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheL...
Gender and cancer immunotherapy efficacy
The Lancet Oncology in conversation with - June 01, 2018 06:30 - 9 minutes ★★★★★ - 1 ratingFabio Conforti talks to The Lancet Oncology about a meta-analysis showing that a patient's sex can affect the efficacy of cancer immunotherapy. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitte...
PROs in regulatory decision making
The Lancet Oncology in conversation with - April 25, 2018 14:30 - 11 minutes ★★★★★ - 1 ratingPaul Kluetz from the US FDA discusses the issues surrounding the use of patient-reported outcomes in regulatory decision making. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancet...
Vulvar field resection
The Lancet Oncology in conversation with - March 29, 2018 06:30 - 13 minutes ★★★★★ - 1 ratingMichael Hoeckel joins The Lancet Oncology to discuss his latest trial on the surgical treatment of vulvar carcinoma based on the theory of ontogenetic cancer fields. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thel...
Chromatin organisation and cancer prognosis
The Lancet Oncology in conversation with - March 01, 2018 07:30 - 7 minutes ★★★★★ - 1 ratingHåvard Emil Danielsen joins The Lancet Oncology to discuss his latest paper on machine learning algorithms to analyse chromatin organisation as a prognostic marker for cancer. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitte...
Trial design for brain metastases: The Lancet Oncology: Jan 2018
The Lancet Oncology in conversation with - December 30, 2017 07:30 - 11 minutes ★★★★★ - 1 ratingRoss Camidge discusses RANO's papers on clinical trial design for patients with brain metastases. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/the...
Lung cancer screening: The Lancet Oncology: November 27, 2017
The Lancet Oncology in conversation with - November 28, 2017 07:30 - 10 minutes ★★★★★ - 1 ratingJohn Field discusses a European position statement on lung cancer screening using low-dose CT. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelan...
Future cancer research priorities in the USA: The Lancet Oncology Commission: October 31, 2017
The Lancet Oncology in conversation with - November 01, 2017 06:30 - 10 minutes ★★★★★ - 1 ratingCommission co-chairs Chi Van Dang and Elizabeth M. Jaffee discuss a new Lancet Oncology Commission on cancer treatment and care in the USA. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.co...
Cancer in Peru: The Lancet Oncology
The Lancet Oncology in conversation with - September 28, 2017 14:30 - 19 minutes ★★★★★ - 1 ratingBen Anderson talks about cancer care and cancer trends in Peru. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/t...
Selective internal radiotherapy for colorectal cancer: The Lancet Oncology: September 2017
The Lancet Oncology in conversation with - September 02, 2017 22:30 - 4 minutes ★★★★★ - 1 ratingRicky Sharma discusses results from three prospective trials on the use of selective internal radiotherapy for liver metastases from colorectal cancer. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https:...
Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017
The Lancet Oncology in conversation with - July 26, 2017 15:00 - 8 minutes ★★★★★ - 1 ratingSamra Turajlic discusses the contribution of small insertions and deletions to tumour-specific antigen analyses. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://in...
Prior radiotherapy and pembrolizumab: The Lancet Oncology: June 28, 2017
The Lancet Oncology in conversation with - June 29, 2017 06:30 - 7 minutes ★★★★★ - 1 ratingPercy Lee discusses the impact of prior radiotherapy on the efficacy of pembrolizumab when used to treat non-small cell lung cancer. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLa...
EANO and palliative care: The Lancet Oncology: June 2, 2017
The Lancet Oncology in conversation with - June 03, 2017 14:30 - 8 minutes ★★★★★ - 1 ratingMartin Taphoorn outlines the importance of palliative care for patients with gliomas. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup ...
Head and neck cancer Series: The Lancet Oncology: April 26, 2017
The Lancet Oncology in conversation with - April 26, 2017 07:00 - 17 minutes ★★★★★ - 1 ratingSandro Porceddu discusses the new Lancet Oncology Series on head and neck cancer. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup h...
<sup>18</sup>F-FDG PET/CT for multiple myeloma: The Lancet Oncology: April, 2017
The Lancet Oncology in conversation with - March 30, 2017 22:30 - 5 minutes ★★★★★ - 1 ratingMichele Cavo discusses the International Myeloma Working Group’s recommendations on the use of 18F-FDG PET/CT for patients with multiple myeloma and other plasma cell dyscrasias. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twi...
Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017
The Lancet Oncology in conversation with - March 02, 2017 07:30 - 18 minutes ★★★★★ - 1 ratingLesley Seymour discusses the iRECIST guidelines for assessing tumour responses in immunotherapy trials. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.c...
Genomic modelling for radiation dosage: The Lancet Oncology: Feb 1 2017
The Lancet Oncology in conversation with - February 02, 2017 07:30 - 15 minutes ★★★★★ - 1 ratingJavier Torres-Roca and Louis Harrison join us to discuss their work on genome modelling and its uses in calculating the appropriate radiation dosage. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://...
Cancer survivorship in the USA: The Lancet Oncology: 30 December
The Lancet Oncology in conversation with - December 30, 2016 08:00 - 11 minutes ★★★★★ - 1 ratingAnn Partridge talks about cancer survival in the USA. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetme...
Non-small cell lung cancer: The Lancet Oncology and The Lancet Respiratory Medicine: November 4, 2016
The Lancet Oncology in conversation with - November 05, 2016 13:30 - 13 minutes ★★★★★ - 1 ratingRafael Rossell discusses RET inhibitors and non-small cell lung cancer. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebo...
Quality of life and low-grade glioma: The Lancet Oncology: 31 October, 2016
The Lancet Oncology in conversation with - October 31, 2016 07:00 - 11 minutes ★★★★★ - 1 ratingBrigitta Baumert discusses her article on quality of life in patients with high-risk, low-grade glioma. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.c...
Renal surveillance: The Lancet Oncology: August 30, 2016
The Lancet Oncology in conversation with - September 01, 2016 14:30 - 9 minutes ★★★★★ - 1 ratingBrian Rini discusses active surveillance for patients with metastatic renal cell carcinoma. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancet...
Multiple myeloma: The Lancet Oncology: July 26, 2016
The Lancet Oncology in conversation with - July 27, 2016 14:30 - 10 minutes ★★★★★ - 1 ratingShaji Kumar discusses updated consensus criteria from the International Myeloma Working Group for response and minimal residual disease assessment in multiple myeloma. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/th...
HPV vaccination in Japan: The Lancet Oncology: June 28, 2016
The Lancet Oncology in conversation with - June 30, 2016 14:30 - 15 minutes ★★★★★ - 1 ratingCatherine Sauvaget and Ryo Konno discuss Japan’s low uptake of screening programmes for breast and cervical cancer. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https:/...
Antibody-drug conjugates for cancer therapy: The Lancet Oncology: June 01, 2016
The Lancet Oncology in conversation with - June 02, 2016 07:00 - 9 minutes ★★★★★ - 1 ratingAnish Thomas discusses use of antibody-drug conjugates for cancer therapy. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://fac...
Ethical issues in paediatric oncology trials: The Lancet Oncology: April 26, 2016
The Lancet Oncology in conversation with - April 27, 2016 14:30 - 15 minutes ★★★★★ - 1 ratingJean-Claude Dupont and François Doz discuss ethical issues in paediatric oncology clinical trials. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/th...
Medulloblastoma: The Lancet Oncology: March 11, 2016
The Lancet Oncology in conversation with - March 12, 2016 07:30 - 9 minutes ★★★★★ - 1 ratingMichael Taylor discusses treatment approaches to the rare brain tumour that generally affects children, medulloblastoma. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol ht...
NAB-paclitaxel and breast cancer: The Lancet Oncology: February 8, 2016
The Lancet Oncology in conversation with - February 11, 2016 07:30 - 8 minutes ★★★★★ - 1 ratingSibylle Loibl discusses the findings and clinical implications of the GeparSepto trial. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgrou...
Rare cancers: The Lancet Oncology | February 2, 2016
The Lancet Oncology in conversation with - February 03, 2016 15:30 - 9 minutes ★★★★★ - 1 ratingDr. Richard Carvajal discusses aspects of treatment and research for rare cancers. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup htt...
Mantle-cell lymphoma: The Lancet Oncology: January 2016
The Lancet Oncology in conversation with - December 24, 2015 14:00 - 16 minutes ★★★★★ - 1 ratingDiscussion of two new treatment approaches to indolent lymphoma and mantle-cell lymphoma, haematological diseases with generally poor response to chemotherapy. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet ...